Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
2011

Effects of Tetraiodothyroacetic Acid on Cancer Cells

publication 10 minutes Evidence: high

Author Information

Author(s): Lin Hung-Yun, Landersdorfer Cornelia B., London David, Meng Ran, Lim Chang-Uk, Lin Cassie, Lin Sharon, Tang Heng-Yuan, Brown David, Van Scoy Brian, Kulawy Robert, Queimado Lurdes, Drusano George L., Louie Arnold, Davis Faith B., Mousa Shaker A., Davis Paul J.

Primary Institution: Ordway Research Institute, Albany, New York, United States of America

Hypothesis

Tetraiodothyroacetic acid (tetrac) inhibits cancer cell proliferation and can be enhanced when combined with other chemotherapeutic agents.

Conclusion

Tetrac and its nanoparticulate form effectively inhibit cancer cell proliferation, with the nanoparticle showing greater potency.

Supporting Evidence

  • Tetrac inhibits the proliferation of cancer cells in a concentration-dependent manner.
  • Nano-tetrac shows a higher potency and larger anti-proliferative effect than unmodified tetrac.
  • Combinations of tetrac with resveratrol and cetuximab resulted in approximately additive anti-proliferative effects.

Takeaway

Tetrac is a special medicine that helps stop cancer cells from growing, and when it's made into tiny particles, it works even better.

Methodology

The study used a perfusion bellows cell culture system to test the effects of tetrac and nano-tetrac on various cancer cell lines over time.

Limitations

The study's in vitro model may not fully replicate the complexities of in vivo environments, such as tissue penetration and immune response.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1371/journal.pcbi.1001073

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication